Literature DB >> 25128087

SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy.

Eun Young Kim1, Yi Zhang2, Ilimbek Beketaev1, Ana Maria Segura3, Wei Yu4, Yutao Xi5, Jiang Chang6, Jun Wang7.   

Abstract

Cardiomyopathy presents a major health issue and is a leading cause of heart failure. Although a subset of familial cardiomyopathy is associated with genetic mutations, over 50% of cardiomyopathy is defined as idiopathic, the mechanisms underlying which are under intensive investigation. SUMO conjugation is a dynamic posttranslational modification that can be readily reversed by the activity of sentrin-specific proteases (SENPs). However, whether SENPs are implicated in heart disease pathophysiology remains unexplored. We observed a significant increase in the level of SENP5, a SUMO isopeptidase, in human idiopathic failing hearts. To reveal whether it plays a role in the pathogenesis of cardiac muscle disorders, we used a gain-of-function approach to overexpress SENP5 in murine cardiomyocytes (SENP5 transgenic, SENP5-Tg). Overexpression of SENP5 led to cardiac dysfunction, accompanied by decreased cardiomyocyte proliferation and elevated apoptosis. The increase in apoptosis preceded other detectable pathological changes, suggesting its causal link to cardiomyopathy. Further examination of SENP5-Tg hearts unveiled a decrease in SUMO attachment to dynamin related protein (Drp1), a factor critical for mitochondrial fission. Correspondingly, the mitochondria of SENP5-Tg hearts at an early developmental stage were significantly larger compared with those in the control hearts, suggesting that desumoylation of Drp1 at least partially accounts for the cardiac phenotypes observed in the SENP5-Tg mice. Finally, overexpression of Bcl2 in SENP5-Tg hearts improved cardiac function of SENP5-Tg mice, further supporting the notion that SENP5 mainly targets mitochondrial function in vivo. Our findings demonstrate an important role of the desumoylation enzyme SENP5 in the development of cardiac muscle disorders, and point to the SUMO conjugation pathway as a potential target in the prevention/treatment of cardiomyopathy. This article is part of a Special Issue entitled "Mitochondria: From Basic Mitochondrial Biology to Cardiovascular Disease".
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cardiomyopathy; Mitochondria; SENP5; SUMO

Mesh:

Substances:

Year:  2014        PMID: 25128087     DOI: 10.1016/j.yjmcc.2014.08.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  31 in total

1.  Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.

Authors:  Yu Liu; Dan Zhao; Fang Qiu; Ling-Ling Zhang; Shang-Kun Liu; Yuan-Yuan Li; Mei-Tong Liu; Di Wu; Jia-Xin Wang; Xiao-Qing Ding; Yan-Xin Liu; Chang-Jiang Dong; Xiao-Qi Shao; Bao-Feng Yang; Wen-Feng Chu
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

Review 2.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 3.  Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases.

Authors:  Jun-Ichi Abe; Uday G Sandhu; Nguyet Minh Hoang; Manoj Thangam; Raymundo A Quintana-Quezada; Keigi Fujiwara; Nhat Tu Le
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  DJ-1 protects the heart against ischemia-reperfusion injury by regulating mitochondrial fission.

Authors:  Yuuki Shimizu; Jonathan P Lambert; Chad K Nicholson; Joshua J Kim; David W Wolfson; Hee Cheol Cho; Ahsan Husain; Nawazish Naqvi; Li-Shen Chin; Lian Li; John W Calvert
Journal:  J Mol Cell Cardiol       Date:  2016-04-22       Impact factor: 5.000

Review 5.  Sub-cellular localization specific SUMOylation in the heart.

Authors:  Nhat-Tu Le; James F Martin; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-24       Impact factor: 5.187

Review 6.  Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology.

Authors:  Stephanie M Adaniya; Jin O-Uchi; Michael W Cypress; Yoichiro Kusakari; Bong Sook Jhun
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-13       Impact factor: 4.249

Review 7.  Post-translational Modifications in Heart Failure: Small Changes, Big Impact.

Authors:  Ahyoung Lee; Jae Gyun Oh; Przemek A Gorski; Roger J Hajjar; Changwon Kho
Journal:  Heart Lung Circ       Date:  2015-12-04       Impact factor: 2.975

Review 8.  Ubiquitin and Ubiquitin-like proteins in cardiac disease and protection.

Authors:  Jie Li; John A Johnson; Huabo Su
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 9.  Drp1-dependent mitochondrial fission in cardiovascular disease.

Authors:  Jia-Yu Jin; Xiang-Xiang Wei; Xiu-Ling Zhi; Xin-Hong Wang; Dan Meng
Journal:  Acta Pharmacol Sin       Date:  2020-09-10       Impact factor: 6.150

Review 10.  Mitochondrial Bioenergetics and Dynamism in the Failing Heart.

Authors:  Giampaolo Morciano; Veronica Angela Maria Vitto; Esmaa Bouhamida; Carlotta Giorgi; Paolo Pinton
Journal:  Life (Basel)       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.